Virovek, Inc. Email Format
Biotechnology ResearchTexas, United States11-50 Employees
Virovek, Inc. is a Houston-based biotechnology company focused on customized and large-scale production of adeno-associated virus vectors for research. Its technology portfolio includes BAC-to-AAV and toxin-based cell ablation approaches, enabling vector production across serotypes at high concentrations for use in advanced studies. Since 2006, the company has produced thousands of AAV vectors for researchers at universities, non-profit institutions, and industry partners worldwide. The firm also provides gene cloning and baculovirus production, and its proprietary technologies are available for non-exclusive licensing. Its client base spans the Americas and Eurasia, and in October 2023 the company appointed Peter L. Hoang as chief executive officer.